Sano blog | Sano Marketing Team (34)

patient recruitment rare disease

Navigating rare disease patient recruitment

Rare diseases may impact a small portion of the population, yet their significance is profound. And while rare disease patient recruitment might seem similar to...

patient recruitment genetic testing

Clinical trial enrollment planning: The impact of genetics in precision medicine

Genetics has become a defining factor in how clinical trials are designed, who qualifies, and how enrollment is planned. Genetic variation influences both disea...

genetic testing neurodegenerative disease patient engagement

Hope and progress: Light the Way at the ENCALS meeting

Last month, our team had the pleasure of attending the European Network to Cure ALS (ENCALS) meeting, an annual gathering that brings together some of the brigh...

genetic testing neurodegenerative disease patient engagement

£330K grant awarded to support and engage patients at risk of MND/ALS

£330K grant awarded to support and engage patients at risk of MND/ALS, and track the psychological impact of genetic testing.

patient engagement

Connecting for success: The power of purposeful participant engagement

This webinar, featuring Sano Genetics team members Ross Rounsevell and George Bowley, highlights the importance of purposeful participant engagement in research...

industry report rare disease genetic testing

Alpha-1 Antitrypsin Deficiency report: Impact and diagnosis

Our latest insights report focuses on Alpha-1 Antitrypsin Deficiency (AATD), a rare genetic disorder with significant implications for both lung and liver healt...

genetic testing neurodegenerative disease

Webinar recap: International perspectives on genetic testing in ALS

This webinar, hosted by Paul Wicks and featuring a panel of experts in ALS and genetics, focuses on the challenges and variability in genetic testing and counse...

precision medicine protocol design

Clinical trial design in precision medicine: 7 CROs and protocol partners

Clinical trial design and protocol development sit at the foundation of every successful study. The choices made at this stage, from study type and endpoint sel...

genetic epidemiology neurodegenerative disease

Webinar recap: Does the age of onset in SOD1 ALS affect the speed of progression?

Mutations in the SOD1 gene were the first identified genetic cause of ALS, discovered in 1993. Yet SOD1-ALS accounts for only approximately 2% of all ALS cases,...

protocol design

Navigating smooth clinical trials: Tips for pharma and biotech sponsors to avoid study rescue

Clinical trials play a crucial role in the development of pharmaceutical and biotech products. However, unforeseen challenges can arise during the trial process...

Clinical research blog